Y. Gong

Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma.

H. Kato, T. Ohira, T. Hirano, 2003, Lung cancer.

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

H. Kato, T. Ohira, T. Hirano, 2001, British Journal of Cancer.

Validation Analysis Using Immunohistochemistry of Non-small Cell Lung Cancer-associated Proteins Detected by Two-dimensional Polyacrylamide Gel Electrophoresis

H. Kato, T. Ohira, T. Hirano, 2007 .

[Mutational analysis of EGFR and K-RAS in Chinese patients with non-small cell lung cancer].

F. Liu, G. Zhu, Xiao-Hua Hu, 2007, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

Identification of postoperative adjuvant chemotherapy responders in non‐small cell lung cancer by novel biomarker

H. Kato, T. Ohira, M. Tsuboi, 2005, International journal of cancer.

Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis

H. Kato, T. Hirano, K. Yoshida, 2002, British Journal of Cancer.

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

H. Kato, Y. Suga, T. Hirano, 2008, British Journal of Cancer.

Proteins Secreted by Lung Adenocarcinoma Cells -Identification of Candidate Diagnosis Markers from Culture Supernatants of Dissected Tumor Tissue-

T. Ohira, T. Hirano, H. Saji, 2010 .

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

H. Kato, Y. Suga, T. Ohira, 2008, British Journal of Cancer.